All research
    Cardiovascular

    Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema.

    Journal
    American journal of ophthalmology
    Published
    December 4, 2026
    Source
    PubMed / NLM
    Credibility
    80 / 100
    Post on X

    Key takeaway

    Clinical trials for diabetes-related vision loss treatments exclude Black adults at roughly twice the rate of white patients due to strict health rules. This matters because it means these common eye medicines aren’t being properly tested on our community. To ensure treatments are safe and effective for us, research must reflect real-world health needs.

    Why this matters for our communities

    Research in cardiovascular helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.

    More in Cardiovascular